EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis

Chi-Yan Lee iD, Koon-Ho Chan

Pharmaceutics · 17.01.2024 · 16 (1) · 120

DOI: 10.3390/pharmaceutics16010120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 17.01.2024. Verfasst von Chi-Yan Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 405B, 4/F, Professori…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research on Neuroimmunological Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis is an important neurological disease affecting millions of young patients globally. It is encouraging that more than ten disease-modifying drugs became available for use in the past two decades. These disease-modifying therapies (DMTs) have different levels of efficacy, routes of administration, adverse effect profiles and concerns for pregnancy. Much knowledge and caution are needed for their appropriate use in MS patients who are heterogeneous in clinical features and severity, lesion load on magnetic resonance imaging and response to DMT. We aim for an updated review of the concept of personalization in the use of DMT for relapsing MS patients. Shared decision making with consideration for the preference and expectation of patients who understand the potential efficacy/benefits and risks of DMT is advocated.

Schlagwörter

Stichwörter der Autor:innen

adverse effectsdisease-modifying therapiesefficacypersonalizationrelapsing multiple sclerosisshared decision making

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 405B, 4/F, Professorial Block, 102 Pokfulam Road, Hong Kong.
  • Neuroimmunology and Neuroinflammation Research Laboratory, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.
  • Research Center of Heart, Brain, Hormone and Healthy Aging, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong.

ORCID-Profile: Chi-Yan Lee

Förderung

  • Research on Neuroimmunological Disorders

Zitieren

APA

Lee, C. Y., & Chan, K. H. (2024). Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis. Pharmaceutics, 16(1), 120. https://doi.org/10.3390/pharmaceutics16010120

Vancouver

Lee CY, Chan KH. Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis. Pharmaceutics. 2024;16(1):120. doi:10.3390/pharmaceutics16010120

BibTeX
@article{Lee2024,
  author = {Lee, Chi-Yan and Chan, Koon-Ho},
  title = {Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {120},
  doi = {10.3390/pharmaceutics16010120}
}
Kostenlos starten →